RefillRx Competitive Intelligence|Ad Analysis by SocialPeta
Competitive intelligence is the first step in our marketing intelligence work and one of the most important parts. Only when we understand the details of our competitors can we formulate a correct and effective marketing strategy.
In this report, SocialPeta analyzes the RefillRx's ad analysis from multiple aspects and helps you see the competitive intelligence of top grossing apps RefillRx.
Now, I'll tell you how to gain a competitive advantage by SocialPeta.
1. Basic Information of RefillRx
App Name : RefillRx
Logo:
OS : iOS
Network : Facebook,Instagram,Messenger
Developer : Rx30
Publisher : Instagram,Facebook
Total creative ads during the time period : 49
Duration : 546
Popularity : 4,879
Check ASO Keywords of RefillRx
2. RefillRx’s Competitive Intelligence
what is competitive intelligence? Competitive intelligence is the most important part of our marketing. Only when we fully understand the overall situation of our competitors and the market can we make accurate judgments.
Before advertising, we usually use various tools, such as SocialPeta, to check the details of competitors' ads. In this report, we will analyze the recent advertising performance of advertiser RefillRx in detail to understand its advertising strategy.
Trend of Category
There are many types of creatives. We mainly analyze the trend of the ad creative category of RefillRx in the recent period. As of 2021-05-03, among the RefillRx‘s ad creative, the Html category's proportion is 0.0%, Video category's proportion is 0.0%, Playable Ads category's proportion is 0.0%, Image category's proportion is 100.0%, Carousel category's proportion is 0.0%.
Ad Network Analysis
The network that SocialPeta monitors can cover almost all mainstream channels in the world. Understanding the competitor's advertising channels is the first step in marketing work. According to the analysis of SocialPeta, we can see that in the date of 2021-05-03, RefillRx's the proportion of networks impressions are placed like this:
Facebook's proportion is 33.33%,
Instagram's proportion is 33.33%,
Messenger's proportion is 33.33%,
's proportion is ,
's proportion is .
In the date of 2021-05-03, RefillRx‘s network with the most ads is Facebook and its proportion is 33.33%.
3. Top 3 Ad Creative Analysis of RefillRx
This is the detailed information of the top three ad creatives with the best performance among all ad creatives of RefillRx. We can see some advertising trends.
Top 1 Ad Creative of RefillRx
Ad Details :
Headline :Transfer Prescriptions On-The-Go!
Text :Visit our website to get started today.
Top 2 Ad Creative of RefillRx
Ad Details :
Headline :Transfer Prescriptions On-The-Go!
Text :Visit our website to get started today.
Top 3 Ad Creative of RefillRx
Ad Details :
Headline :Join Our Pharmacy Family!
Text :Visit our website to transfer prescriptions online.
Basic Info of Top 3 Ad Creative
1st | 2nd | 3rd | |
Duration | 149 | 149 | 34 |
Popularity | 603 | 602 | 164 |
Dimensions | 800 x 521 | 800 x 533 | 449 x 600 |
Creative Type | Image | Image | Image |
Network | |||
Related Ads | 2 | 2 | 1 |
Countries | United States | United States | United States,United Kingdom,Canada,Australia |
Language | English | English | English |
Through the above analysis, we can see that the most effective channel for RefillRx in recent advertising is Facebook, and the main creative type is Image.
In conclusion: The above is a free RefillRx's competitive intelligence analysis report. To do a good job of advertising, long-term accumulation is required. we need to constantly check the latest trends and competitive intelligence data. With the use of competitive intelligence tools like SocialPeta, Guangdada(Chinese version of SocialPeta), we can improve our ROI, and make competitor‘s fans ours. I hope that this ad creative analysis report will allow you to gain more.
If you want to check the relevant intelligence analysis of other apps similar to RefillRx, you can click the app name below to view related reports, or you can find more info in ASOTools.